Raman micro spectroscopy for in vitro drug screening: subcellular localisation and interactions of doxorubicin

Literature Information

Publication Date 2015-03-31
DOI 10.1039/C5AN00256G
Impact Factor 4.616
Authors

Z. Farhane, F. Bonnier, A. Casey, H. J. Byrne


View Original

Abstract

Vibrational spectroscopy, including Raman micro spectroscopy, has been widely used over the last few years to explore potential biomedical applications. Indeed, Raman micro spectroscopy has been demonstrated to be a powerful non-invasive tool in cancer diagnosis and monitoring. In confocal microscopic mode, the technique is also a molecularly specific analytical tool with optical resolution which has potential applications in subcellular analysis of biochemical processes, and therefore as an in vitro screening tool of the efficacy and mode of action of, for example, chemotherapeutic agents. In order to demonstrate and explore the potential in this field, established, model chemotherapeutic agents can be valuable. In this study paper, Raman micro spectroscopy coupled with confocal microscopy were used for the localization and tracking of the commercially available drug, doxorubicin (DOX), in the intracellular environment of the lung cancer cell line, A549. Cytotoxicity assays were employed to establish clinically relevant drug doses for 24 h exposure, and Confocal Laser Scanning Fluorescence Microscopy was conducted in parallel with Raman micro spectroscopy profiling to confirm the drug internalisation and localisation. Multivariate statistical analysis, consisting of PCA (principal components analysis) was used to highlight doxorubicin interaction with cancer cells and spectral variations due to its effects before and after DOX spectral features subtraction from nuclear and nucleolar spectra, were compared to non-exposed control spectra. Results show that Raman micro spectroscopy is not only able to detect doxorubicin inside cells and profile its specific subcellular localisation, but, it is also capable of elucidating the local biomolecular changes elicited by the drug, differentiating the responses in different sub cellular regions. Further analysis clearly demonstrates the early apoptotic effect in the nuclear regions and the initial responses of cells to this death process, demonstrating the potential of the technique to monitor the mechanisms of action and response on a molecular level, with subcellular resolution.

Related Literature

Mechanistic aspects of the linear stabilization of non-stationary electrochemical oscillations

Murilo F. Cabral, Raphael Nagao, Elton Sitta

2012-11-01 Paper

DOI: 10.1039/C2CP42890C

Revealing local, enhanced optical field characteristics of Au nanoparticle arrays with 10 nm gap using scattering-type scanning near-field optical microscopy

Tian-You Cheng, Hui-Hsien Wang, Sheng Hsiung Chang, Jen-You Chu, Juen-Haw Lee

2013-02-15 Paper

DOI: 10.1039/C3CP43270J

A new hematite photoanode doping strategy for solar water splitting: oxygen vacancy generation

Tae-Youl Yang, Ho-Young Kang, Uk Sim, Young-Joo Lee, Ji-Hoon Lee, Byungjin Koo, Ki Tae Nam, Young-Chang Joo

2012-12-05 Paper

DOI: 10.1039/C2CP44352J

A new type of low-cost counter electrode catalyst based on platinum nanoparticles loaded onto silicon carbide (Pt/SiC) for dye-sensitized solar cells

Sining Yun, Liang Wang, Chunyu Zhao, Yanxiang Wang, Tingli Ma

2013-02-01 Communication

DOI: 10.1039/C3CP44048F

The fundamental chemical equation of aromaticity

2013-01-08 Paper

DOI: 10.1039/C2CP44075J

Towards a highly-efficient fuel-cell catalyst: optimization of Pt particle size, supports and surface-oxygen group concentration

Navaneethan Muthuswamy, Jose Luis Gomez de la Fuente, Piotr Ochal, Rajiv Giri, Steinar Raaen, Svein Sunde, Magnus Rønning, De Chen

2013-01-14 Paper

DOI: 10.1039/C3CP43659D

Single-crystal adsorptioncalorimetry and density functional theory of CO chemisorption on fcc Co{110}

Kristine Liao, Vittorio Fiorin, David S. D. Gunn, Stephen J. Jenkins, David A. King

2013-02-13 Paper

DOI: 10.1039/C3CP43836H

General treatment of the multimode Jahn–Teller effect: study of fullerenecations

Harry Ramanantoanina, Matija Zlatar, Pablo García-Fernández, Claude Daul

2012-11-22 Paper

DOI: 10.1039/C2CP43591H

You might also like

Compound Q&A

What industries use 4-(4-tert-Butylphenyl)-1H-pyrazol-3-amine (CAS: 1015845-73-4)?

4-(4-tert-Butylphenyl)-1H-pyrazol-3-amine finds applications in various industri...

1015845-73-44-(4-tert-Butylpheny...
Compound Q&A

What industries use H3TATAB (CAS: 63557-10-8)?

H3TATAB is used in the pharmaceutical industry for the synthesis of certain orga...

63557-10-8H3TATAB
Compound Q&A

What are the main uses of 1-Ethyl-3-fluorobenzene (CAS: 696-39-9)?

1-Ethyl-3-fluorobenzene (CAS: 696-39-9) is primarily used as a precursor in the ...

696-39-91-Ethyl-3-fluorobenz...
Compound Q&A

What are the main uses of 1-(tert-Butoxycarbonyl)-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid (CAS: 851484-94-1)?

1-(tert-Butoxycarbonyl)-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid is prim...

851484-94-11-(tert-Butoxycarbon...
Compound Q&A

What are the physical and chemical properties of 1-Cyclobutyl-4-piperidinone (CAS: 359880-05-0)?

1-Cyclobutyl-4-piperidinone (CAS: 359880-05-0) is a colorless or white crystalli...

359880-05-01-Cyclobutyl-4-piper...
Compound Q&A

What is Pyridine-2,6-dicarboxylic acid mono-tert-butyl ester (CAS: 575433-76-0)?

Pyridine-2,6-dicarboxylic acid mono-tert-butyl ester (CAS: 575433-76-0) is a che...

575433-76-0Pyridine-2,6-dicarbo...
Compound Q&A

What is the market or research trend for 2,3-Difluorophenylalanine (CAS: 236754-62-4)?

The market for 2,3-Difluorophenylalanine (CAS: 236754-62-4) is growing with incr...

236754-62-42,3-Difluorophenylal...
Compound Q&A

How is (2-Hydroxy-1-naphthyl)boronic acid (CAS: 898257-48-2) typically synthesized?

(2-Hydroxy-1-naphthyl)boronic acid can be synthesized through the reduction of 2...

898257-48-2(2-Hydroxy-1-naphthy...
1315351-28-0tert-Butyl (5-bromo-...
Compound Q&A

Are there alternatives to 5,7-Dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-yl beta-D-glucopyranoside (CAS: 19833-12-6) in synthesis?

While 5,7-Dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-yl beta-D-gluc...

19833-12-65,7-Dihydroxy-4-oxo-...

Source Journal

Analyst

Analyst
CiteScore: 7.8
Self-citation Rate: 5.6%
Articles per Year: 653

Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.